SH
Steven R Hagen
SVP Manufacturing & Pharmaceut

Steven R Hagen insider trades: Albany Molecular Research (AMRI) stock sales

SVP Manufacturing & Pharmaceut, Albany Molecular Research Last trade Nov 30, 2016 86 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
55
Open-market trades
since 2008
1
Company
last trade 2016

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Steven reports to the SEC

Open-market buys and sales

55 trades reported on SEC Form 4, newest first

DateStockTypeValue
Nov 30, 2016AMRI↓ Sell$150K
Nov 10, 2016AMRI↓ Sell$13K
Aug 9, 2016AMRI↓ Sell$21K
May 13, 2016AMRI↓ Sell$30K
Aug 17, 2015AMRI↓ Sell$20K
Aug 7, 2015AMRI↓ Sell$105K
Jun 8, 2015AMRI↓ Sell$100K
Jun 4, 2015AMRI↓ Sell$15K
Jun 2, 2015AMRI↓ Sell$73K
May 8, 2015AMRI↓ Sell$279K
Mar 17, 2015AMRI↓ Sell$65K
Mar 13, 2015AMRI↓ Sell$8K
Mar 11, 2015AMRI↓ Sell$13K
Feb 23, 2015AMRI↓ Sell$61K
Feb 18, 2015AMRI↓ Sell$110K
Nov 14, 2014AMRI↓ Sell$169K
Nov 10, 2014AMRI↓ Sell$128K
Aug 28, 2014AMRI↓ Sell$25K
Aug 8, 2014AMRI↓ Sell$205K
Jun 3, 2014AMRI↓ Sell$42K
May 16, 2014AMRI↓ Sell$19K
May 12, 2014AMRI↓ Sell$88K
Feb 27, 2014AMRI↓ Sell$47K
Feb 25, 2014AMRI↓ Sell$38K
Feb 21, 2014AMRI↓ Sell$22K
Feb 19, 2014AMRI↓ Sell$20K
Dec 4, 2013AMRI↓ Sell$27K
Nov 22, 2013AMRI↓ Sell$27K
May 29, 2013AMRI↓ Sell$9K
May 10, 2013AMRI↓ Sell$12K
Mar 19, 2013AMRI↓ Sell$4K
Mar 12, 2013AMRI↓ Sell$7K
Mar 7, 2013AMRI↓ Sell$10K
Feb 22, 2013AMRI↓ Sell$8K
Feb 19, 2013AMRI↓ Sell$8K
Nov 5, 2012AMRI↓ Sell$1K
Aug 24, 2012AMRI↓ Sell$3K
Aug 9, 2012AMRI↓ Sell$9K
Jun 5, 2012AMRI↓ Sell$1K
May 15, 2012AMRI↓ Sell$7K
Mar 19, 2012AMRI↓ Sell$3K
Mar 6, 2012AMRI↓ Sell$242
Nov 14, 2011AMRI↓ Sell$1K
Nov 4, 2011AMRI↓ Sell$4K
May 6, 2011AMRI↓ Sell$958
Mar 18, 2011AMRI↓ Sell$3K
Dec 6, 2010AMRI↓ Sell$10K
Nov 14, 2010AMRI↓ Sell$7K
Mar 9, 2010AMRI↓ Sell$2K
Nov 19, 2009AMRI↓ Sell$12K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Steven R Hagen's insider trades

Steven R Hagen is SVP Manufacturing & Pharmaceut at Albany Molecular Research (AMRI). Since Nov 17, 2008, Steven has reported no open-market purchases and 55 sales worth $2.1M on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include shares withheld for taxes (20 filings), option exercises (18 filings), grants and awards (12 filings), shares returned to the company (8 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every AMRI insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.